Courtagen Life Sciences Obtains $8,000,000 New Funding

  • Feed Type
  • Date
    10/7/2011
  • Company Name
    Courtagen Life Sciences
  • Mailing Address
    12 Gill Street Woburn, MA 01801
  • Company Description
    Courtagen Life Sciences, Inc. (“CLS”) provides innovative and disruptive proteomic and genomic products and services to the Life Sciences industry. Our companies deliver tools that enable researchers and clinicians to make better decisions regarding drug development and patient care.
  • Website
    http://www.courtagen.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy